Clindamycin is one of the alternative antibiotics in the therapy of Staphylococcus aureus, particularly in methicillin resistant S. aureus
BACKGROUND Clindamycin is an effective drug to treat Methicillin-Resistant Staphylococcus Aureus (MRSA). Reporting S. aureus as susceptible to
BACKGROUND Clindamycin is an effective drug to treat Methicillin-Resistant Staphylococcus Aureus (MRSA). Reporting S. aureus as susceptible to
Clindamycin is active against gram-positive organisms (Staphylococcus aureus, Staphylococcus epidermidis, streptococci and Cutibacterium) and gram-negative
Trimethoprim Sulfamethoxazole Plus Clindamycin for Treatment of Staphylococcus aureus Endocarditis. Aug.
Clindamycin is one of the alternative antibiotics in the therapy of Staphylococcus aureus, particularly in methicillin resistant S. aureus
Staphylococcus aureus isolates with inducible clindamycin resistance may lead to therapeutic failure on treating with Clindamycin.
The intraphagocytic bioactivities for Staphylococcus aureus of amoxicillin, clindamycin Clindamycin phosphate 1.2% together with
Pneumonia, S. aureus, and Clindamycin suppresses virulence expression in inducible clindamycin-resistant Staphylococcus aureus strains.
Comments